Drug recall · September 4, 2013
Bethel 30 capsules recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once marketed in the U.S. but removed due to safety reasons, making this product an unapproved new drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Bethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New York
- Lots / codes
Lot #: 120514, EXP: 12/2014
- Quantity
- 18,678 bottles
- Company
- Bethel Nutritional Consulting, Inc, New York, NY
- Distribution
- Nationwide. Product was also available for sale via internet
- Initiated
- June 11, 2013 · Voluntary: Firm initiated
- Classified
- August 23, 2013
- Reported
- September 4, 2013
- Ended
- June 27, 2018
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.